NCT02092870View on ClinicalTrials.gov

Adipose Derived Regenerative Cellular Therapy of Chronic Wounds

PHASE2CompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

September 30, 2013

Primary Completion Date

September 30, 2015

Study Completion Date

September 9, 2019

Conditions
Diabetic FootVenous UlcerPressure Ulcer
Interventions
DRUG

Adipose derived stem cells

ASCs harvested from autologous lipoaspirate

Trial Locations (1)

90048

Tower Outpatient Surgical Center, Los Angeles

All Listed Sponsors
lead

Tower Outpatient Surgical Center

OTHER

NCT02092870 - Adipose Derived Regenerative Cellular Therapy of Chronic Wounds | Biotech Hunter | Biotech Hunter